ELSAH-PROJEKT SETZT NEUE MASSSTÄBE BEI WEARABLES

NEXT STORY
Panag Pharma Completes Phase 3 Trial With Awaye™
PREV STORY
Change in Orion Corporation’s holding of treasury shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Innovation Pharmaceuticals Data from Phase 2 Brilacidin Oral Mucositis (OM) Trial in Head and Neck Cancer Show Notable Reductions in Median Duration of Severe OM and in Number of Unplanned Visits/Hospital Admissions Due to OM

author_avatar
NASDAQ Market News

The global medical headwalls marketis expected to reach US$ 1,209.1 million by 2027 from US$ 787.1 millionin 2019

author_avatar
NASDAQ Market News

SOTIO to Present Biomarker Data from its SOV01 – DCVAC/OvCa Phase 2 Study in 1st line Ovarian Cancer at the 2021 ASCO Annual Meeting

author_avatar
NASDAQ Market News